Surge Care
Founded 2021 · 30 employees on LinkedIn · 1 known investors
Company operating a biomarker discovery platform (Stabl) that applies multiomics, systems biology, and machine learning to extract clinically actionable biomarkers from complex datasets. Its product PreCyte SSI predicts the risk of postoperative surgical complications to help clinicians personalize perioperative care in hospitals.
Investors · 1
Frequently asked questions
- What does Surge Care do?
- Company operating a biomarker discovery platform (Stabl) that applies multiomics, systems biology, and machine learning to extract clinically actionable biomarkers from complex datasets. Its product PreCyte SSI predicts the risk of postoperative surgical complications to help clinicians personalize perioperative care in hospitals.
- Who are Surge Care's investors?
- Surge Care's investors include Boutique Venture Partners.